Table 1 The basic patient data and median and 25th–75th percentile of plasma D-dimer, CEA levels and CTC positive rate in 41 Gastric Cancer patients

 Male

34

10 (29.41%)

1.10 (0.58–2.35)

2.80 (1.58–19.53)

 Female

7

3 (42.85%)

1.30 (0.50–3.30)

4.21 (1.63–19.46)

  ≤ 61

19

7 (36.84%)

1.30 (0.50–3.50)

2.79 (1.38–19.46)

 >61

22

6 (27.27%)

1.05 (0.70–1.77)

3.15 (1.70–10.25)

 G1–G2

14

4 (28.57%)

0.85 (0.48–1.62)

4.27 (2.92–25.30)

 G3–G4

27

9 (33.33%)

1.30 (0.70–3.30)

2.25 (1.38–5.46)

 IIIB

11

0

0.50 (0.30–1.10)

4.34 (2.16–19.46)

 IV

30

13

1.50 (0.87–3.35)

2.43 (1.58–10.25)

 M0

20

3

0.95 (0.50–1.65)

2.60 (1.39–14.59)

 M1

16

6

1.10 (0.62–2.12)

2.99 (1.78–39.44)

 M2

5

4

7.10 (2.45–26.80)

4.70 (1.56–64.81)

 R0

20

3

1.00 (0.35–1.65)

2.50 (1.39–4.76)

 R1

15

7

1.60 (0.70–3.80)

2.96 (1.63–17.83)

 Other

6

2

1.40 (0.80–9.35)

28.11 (2.40–157.25)